Home Articles List Article Information
Benha Journal of Applied Sciences
Journal Archive
Volume Volume 9 (2024)
Volume Volume 8 (2023)
Volume Volume 7 (2022)
Volume Volume 6 (2021)
Volume Volume 5 (2020)
Volume Volume 4 (2019)
Volume Volume 3 (2018)
Volume Volume 2 (2017)
Volume Volume 1 (2016)
Kasab, I., Rezk, M., Aglan, B., Saleh, M. (2021). Role of selective pulmonary vasodilators in management of hypertensive ventricular septal defect in pediatrics. Benha Journal of Applied Sciences, 6(5), 21-26. doi: 10.21608/bjas.2021.198192
I.M. Kasab; M.E. Rezk; B.M. Aglan; M.A. Saleh. "Role of selective pulmonary vasodilators in management of hypertensive ventricular septal defect in pediatrics". Benha Journal of Applied Sciences, 6, 5, 2021, 21-26. doi: 10.21608/bjas.2021.198192
Kasab, I., Rezk, M., Aglan, B., Saleh, M. (2021). 'Role of selective pulmonary vasodilators in management of hypertensive ventricular septal defect in pediatrics', Benha Journal of Applied Sciences, 6(5), pp. 21-26. doi: 10.21608/bjas.2021.198192
Kasab, I., Rezk, M., Aglan, B., Saleh, M. Role of selective pulmonary vasodilators in management of hypertensive ventricular septal defect in pediatrics. Benha Journal of Applied Sciences, 2021; 6(5): 21-26. doi: 10.21608/bjas.2021.198192

Role of selective pulmonary vasodilators in management of hypertensive ventricular septal defect in pediatrics

Article 4, Volume 6, Issue 5, September 2021, Page 21-26  XML PDF (299.18 K)
Document Type: Original Research Papers
DOI: 10.21608/bjas.2021.198192
View on SCiNiTO View on SCiNiTO
Authors
I.M. Kasab; M.E. Rezk; B.M. Aglan; M.A. Saleh
Cardiothoracic surgery, Dept., Faculty of Medicine, Benha Univ., Benha, Egypt
Abstract
Background: Septal ventricular defect is an acyanotic heart condition that requires operation. Pulmonary artery pressure is a major determinant in the outcome of surgery Objectives: Evaluation of the usage of antihypertensive pulmonary medicines after surgical closure of septal ventricular hypertension defects. Materials: 60 patients were chosen for primary ventricular septal defect surgical repair. Instances with congenital abnormalities were eliminated rather than PDA or ASD and redo cases. These cases were divided into two groups (each of 30 patients) one with oral sildenafil and the other with no oral sildenafil. Results: The mean pulmonary artery pressure of sildenafil dropped from 66.4 ± 9.1 to 42.5 ± 3.6 mmHg and decreased to 50.2 ± 5.3 mmHg in the control group. Conclusion: Pulmonary antihypertensive medicines have an essential role in reducing pulmonary artery pressure and provide improved surgical outcomes.
Keywords
Ventricular septal defect; pulmonary hypertension; pulmonary vasodilators
Statistics
Article View: 120
PDF Download: 315